Bayer AG (BAYNd)
FRA • Healthcare
April 2, 2026 at 16:30 UTC
About Bayer AG
Bayer AG is a life-science company that develops medicines and agricultural solutions and brings them to market under a single operating philosophy: rigorous science, reliable supply, and guidance that clinicians and growers can use in routine settings. Research feeds clinical and field programs, manufacturing turns validated methods into repeatable production, and local teams adapt access and stewardship to regional rules. The enterprise treats discovery and delivery as one chain, with safety and labeling woven into each step. Healthcare units focus on therapies used in everyday practice, while crop-related units support resilience on farms and in supply networks. Across regions, the aim is to make complex innovation feel workable: instructions that fit the day, inventories that show up, and data that closes the loop between use and improvement. In the healthcare and materials ecosystem, Bayer acts as a long-horizon partner to systems that cannot pause.
Analyst Ratings
Fundamentals & Financials
TTM is calculated as the sum of the four most recently completed quarters. This is a standard approach when monthly or real-time data is not available.
Income Statement
Balance Sheet
Financial Highlights
Dividends History
Split History
Earnings Calendar
Technical Indicators
Bayer AG's Technical Indicators Summary
Bayer presents a neutral technical picture with mixed timeframes and muted momentum. Short-term moving averages sit around the current price and some medium-term averages offer resistance, while longer-term EMAs are supportive; RSI and CCI are balanced and MACD is marginally negative. ADX indicates a lackluster trend and ATR points to moderate volatility, while OBV shows positive cumulative volume yet classic pivots are slightly above the market. Technical takeaway: Neutral — neither buyers nor sellers hold a clear advantage.
| Indicator | Value |
|---|---|
RSI (14) | 49.86 |
Stochastic %K (14, 3, 3) | 78.31 |
CCI (20) | 58.29 |
WPR (14) | -22.74 |
Momentum (10) | 1.23 |
MFI | 60.09 |
MACD Level (12, 26) | -0.53 |
Bollinger Bands | $36.85 - $40.87 |
ATR (14) | $1.42 (3.58%) |
ADX (14) | 20.21 |
OBV | 90,496,787 |
Classic Pivot Point | $39.97 |
Fibonacci Pivot Point | $39.97 |
Exponential Moving Averages | $33.88 - $39.93(5 indicators) |
Simple Moving Averages | $38.75 - $42.02(5 indicators) |
Get premium market insights delivered directly to your inbox.
Today's Snapshot
The day wrapped with modest participation in BAYNd, as overall volume reached only 0.35× average. By the final print, sector returns hovered near -0.06%, reflecting a largely neutral environment. BAYNd drifted on light volume as the sector held a broadly neutral tone.
Price Change
from €39.7 close
+€0
Trading Volume
Below avg (3.3M)
1.1M
vs S&P 500 Today
Moderate Underperformance
-0.49%
52-Week Position
Upper range
67.9%
Updated: April 2, 2026 at 15:08 UTC
Quote Summary
BAYNd Headlines
Biotech, Pharma Stocks Draw Fresh Valuation Focus
April 2, 2026
Moderna, Mexico sign mRNA vaccine pact
February 11, 2026